• shareIcon

    What Research has been done on Kala Azar?

    Communicable Diseases By Bhadra Kamalasanan , Onlymyhealth editorial team / Jul 25, 2011
    What Research has been done on Kala Azar?

    As the tests for diagnosis and treatment of kala-azar are not satisfactory several studies are ongoing to develop effective and reliable tests for diagnosis of the disease and newer drugs for its treatment.

    Visceral leishmaniasis, also called Kala azar, is a major public health problem that has been an obstacle to socioeconomic development in the country. As of now, a lot of space technologies offer new opportunities to allow rapid appraisal of the endemic areas, stipulation of the trustworthy estimation of populations that is at risk and prediction of distribution of the disease in areas that are difficult to access and lack baseline data and guiding intervention strategies.

    kala azar research in India

    One of the most important reasons why people are highly concerned about the disease is the increase in industrialization which has caused an increase in travel as well as migration of population in the global economy. There have also been associations made between kala azar and AIDS, which has further compounded the problem and drawn the attention of the international community ever since both the disease have been found to have immunosuppressive effect on the host system; this allows the parasites to survive.
    In India, kala azar is said to have existed since 1850 in Bengal, which thereafter extended to Assam and then to UP and then to other parts of the country. If kala azar is left untreated, it can be life-threatening. The WHO says that around 200,000 to 400,000 new cases of the disease occur every year and about 60 percent of the cases tend to develop in the Indian subcontinent alone; in India, over 186 mllion people are at the risk of suffering from the disease.


    An ongoing collaboration between UNM and Rajendra Memorial Research Institute in Patna aims to develop a foundation for paratransgenic control of the disease. Currently, a 2-year NIH R21 proposal is under review, which involves collaboration between UNM, RMRI and WRAIR.

     

    Read more articles on Kala Azar.

     

    Disclaimer

    All possible measures have been taken to ensure accuracy, reliability, timeliness and authenticity of the information; however Onlymyhealth.com does not take any liability for the same. Using any information provided by the website is solely at the viewers’ discretion. In case of any medical exigencies/ persistent health issues, we advise you to seek a qualified medical practitioner before putting to use any advice/tips given by our team or any third party in form of answers/comments on the above mentioned website.

    This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK